Sestamibi scintigraphy reveals adenocarcinoma of the lung

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 32, Issue 1, 2005, Pages 139-

  Malamitsi, J ^a   Papadopoulos, S ^a   Iliadis, K ^a   Pagou, M ^a   Lamprakos, L ^a   Dalianis, K ^a   Efthimiadou, R ^a   Andreou, J ^a  

^a HYGEIA HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; ARTICLE; ATELECTASIS; BRONCHOSCOPY; CANCER DIAGNOSIS; CANCER PATIENT; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; CYTOLOGY; HUMAN; IMAGE ANALYSIS; IMMUNOPHENOTYPING; LUNG ADENOCARCINOMA; MORPHOLOGY; PLEURA EFFUSION; SCINTIGRAPHY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; THORAX; THORAX SURGERY; TUMOR BIOPSY; TUMOR CELL;

ADENOCARCINOMA; COUGH; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; PLEURAL EFFUSION, MALIGNANT; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI;

EID: 12444260656     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-004-1572-3     Document Type: Article

References (2)

1. 99mTc-hexakis-2-methoxy-isobutylisonitrile in the diagnosis and staging of lung cancer. Chest 2002; 122:1361-1364
2. Wong CY, Nuñez R, Bohdiewicz P, et al. Patterns of abnormal FDG uptake by various histological types of non-small cell lung cancer at initial staging by PET. J Nucl Med 2001; 28:1702-1705